¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sleep restriction therapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® symptomatic therapy ÇÑ±Û ´ëÁõ¿ä¹ý
¼³¸í   
  º´ÀÇ ¿øÀÎÀ» Ã£¾Æ ¾ø¾Ö±â °ï¶õÇÑ »óȲ¿¡¼­, °ÑÀ¸·Î ³ªÅ¸³­ º´ÀÇ Áõ»ó¿¡ ´ëÀÀÇÏ¿© Ã³Ä¡¸¦ Çϴ ġ·á¹ý. ¿­ÀÌ ³ôÀ» ¶§¿¡ ¾óÀ½ÁָӴϸ¦ ´ë°Å³ª ÇØ¿­Á¦¸¦ ½á¼­ ¿­À» ³»¸®°Ô Çϴ µûÀ§°¡ ÀÌ¿¡ ¼ÓÇÑ´Ù. 
¿µ¹® radiation therapy ÇÑ±Û ¹æ»ç¼±¿ä¹ý
¼³¸í   
  X¼±, ¥ã¼±ÀÇ ÀüÀÚ¹æ»ç¼±À̳ª ÀüÀÚ¼±, ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÇ ÀÔÀÚ¹æ»ç¼±À» ÀÌ¿ëÇØ, ÁַΠ¾Ç¼º Á¾¾ç Ä¡·á¸¦ ¸ñÀûÀ¸·Î Çϴ ġ·á¹ýÀÌ´Ù. ¾Ï¼¼Æ÷°¡ ÁÖÀ§ÀÇ Á¤»ó¼¼Æ÷º¸´Ùµµ ¹æ»ç¼± °¨¼ö¼ºÀÌ ³ôÀº Á¡À» ÀÌ¿ëÇÏ¿©, Á¤»ó¼¼Æ÷ÀÇ ¼Õ»óÀ» °¡´ÉÇÑ ÇÑ ÃּҷΠ¾ïÁ¦Çϸ鼭 ¾Ï¼¼Æ÷¸¦ ÆÄ±«ÇÑ´Ù. »ç¿ëµÇ´Â ¹æ»ç¼±¿¡´Â ¹ÐºÀ¼Ò¼±¿ø¿¡¼­ ³ª¿À´Â ¥ã¼±, Á÷¼±°¡¼Ó±â¿¡¼­ ¾ò¾îÁö´Â °í¿¡³ÊÁö X¼±°ú ÀüÀÚ¼±, ÅÚ·¹ÄÚ¹ßÆ®ÀåÄ¡¿¡ ÀÇÇÑ 60CoÀÇ ¥ã¼±°ú, º£Å¸Æ®·Ð¿¡ ÀÇÇÑ ÀüÀÚ¼±, »çÀÌÅ©·ÎÆ®·Ð¿¡¼­ ¾ò¾îÁö´Â ¾çÀÚ¼±, Áß¼ºÀÚ¼± µîÀÌ ÀÖ´Ù. 
¿µ¹® radiation therapy ÇÑ±Û ¹æ»ç¼±Ä¡·á
¼³¸í   
  ¹æ»ç¼±ÀÇ »ì±ÕÈ¿°ú³ª ¼¼Æ÷¸¦ Á×À̴ ȿ°ú¸¦ Ä¡·á¿¡ ÀÌ¿ëÇϴ ¹æ¹ýÀ¸·Î, Á¼Àº Àǹ̷Π¾ÏÀÇ ¹æ»ç¼±Ä¡·á¸¦ ÀǹÌÇÑ´Ù. ¾Ï¿¡ ´ëÇÑ ¹æ»ç¼±Ä¡·á´Â ¾Ï¼¼Æ÷¸¦ Á×À̴µ¥ È¿°ú°¡ Å« º£Å¸¼±À» ÁַΠ»ç¿ëÇÑ´Ù. ÇÏÁö¸¸, ÀÌ·± ¹æ»ç¼±Ä¡·á´Â Á¤»ó¼¼Æ÷¿¡µµ Å« ¿µÇâÀ» ³¢ÃÄ ÀÌ¿¡ µû¸¥ ±â´ÉÀÇ Àå¾Ö¸¦ °¡Á®¿Ã ¼ö ÀÖ´Ù. µû¶ó¼­ ¹æ»ç¼±Ä¡·á¿¡ À־´Â ´ÜÁö ±× ¾Ï¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ë»Ó¸¸ ¾Æ´Ï¶ó, Á¤»ó¼¼Æ÷¿¡ ´ëÇÑ ÀÛ¿ëµµ °í·ÁÇÏ¿© ½ÃÇàÇÑ´Ù.
¿µ¹® speech therapy ÇÑ±Û ¾ð¾îÄ¡·á
¼³¸í   
  ¸»À» Á¤È®ÇϰԠ¹ßÀ½ÇÒ ¼ö ¾ø°Å³ª ´õµë´Â È¯ÀÚ¿¡°Ô ¹ßÀ½, ´ëÈ­ µûÀ§ÀÇ ÈÆ·ÃÀ» Àü¹®ÀûÀ¸·Î ÇàÇϴ ġ·á¹ý. 
¿µ¹® therapy ÇÑ±Û ¿ä¹ý
¼³¸í   
  º´À» ³´°Ô Çϴ °Í ¶Ç´Â ±× ¹æ¹ý.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • excessive sleep inertia
    °úµµ¼ö¸é¹«·ÂÁõ
  • electric sleep
    Àü±âÀ¯µµ¼ö¸é, Àü±â¼ö¸é
  • induced sleep
    À¯µµ¼ö¸é
  • multiple sleep latency test
    ¼ö¸éÀẹ±â¹Ýº¹°Ë»ç
  • natural sleep
    ÀÚ¿¬¼ö¸é
  • NREM sleep
    ºñ±Þ¼Ó¾È±¸¿îµ¿¼ö¸é
  • orthodox sleep
    Á¤»ó¼ö¸é
  • obstructive sleep apnea
    Æó¼â¼ö¸é¹«È£Èí
  • obstructive sleep apnea syndrome
    Æó¼â¼ö¸é¹«È£ÈíÁõÈıº
  • prolonged sleep
    Áö¼Ó¼ö¸é
  • paradoxical sleep
    ¿ª¼³¼ö¸é
  • paroxysmal sleep
    ¹ßÀÛ¼ö¸é
  • REM sleep
    ºü¸¥´«¿îµ¿¼ö¸é, ±Þ¼Ó¾È±¸¿îµ¿¼ö¸é, ·½¼ö¸é
  • REM sleep promoting area
    ·½¼ö¸éÃËÁø¿µ¿ª
  • sleep
    Àá, ¼ö¸é
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • acetylsalycylic acid antiplatelet therapy
    Ç×Ç÷¼ÒÆÇ¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • antibiotic therapy
    Ç×»ýÁ¦¿ä¹ý
  • ASA antiplatelet therapy
    (¢¡acetylsalycylic acid antiplatelet therapy) Ç×Ç÷¼ÒÆÇ¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • electroconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý
  • estrogen replacement therapy
    ¿©¼ºÈ£¸£¸ó´ëü¿ä¹ý
  • gene therapy
    À¯ÀüÀÚ¿ä¹ý
  • home oxygen therapy
    °¡Á¤»ê¼Ò¿ä¹ý
  • initial therapy
    ÃʱâÄ¡·á
  • O2 therapy
    »ê¼Ò¿ä¹ý
  • radiation therapy
    ¹æ»ç¼±¿ä¹ý, ¹æ»ç¼±Ä¡·á
  • replacement therapy
    ´ëÄ¡¿ä¹ý
  • speech therapy
    ¾ð¾îÄ¡·á
  • supportive therapy
    ÁöÁö¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sleep attack
    ¼ö¸é¹ßÀÛ
  • sleep-related sinus arrest
    ¼ö¸é°ü·Ã½ÉÀå¹Úµ¿Á¤Áö
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö
  • sleep bruxism
    À̰¥ÀÌ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÇÏ·çÁÖ±â¼ö¸éÀå¾Ö
  • crescendo sleep
    Á¡Áõ¼º¼ö¸é
  • delayed sleep phase
    Áö¿¬¼ö¸éÀ§»ó
  • delayed sleep phase syndrome
    ¼ö¸éÀ§»óÁö¿¬ÁõÈıº
  • delta sleep
    µ¨Å¸¼ö¸é
  • sleep disorder
    ¼ö¸éÀå¾Ö, ¼ö¸éº´
  • sleep drunkenness
    Àá¿¡ÃëÇÑ»óÅÂ
  • sleep-wake schedule disorder
    ¼ö¸é°¢¼ºÀÏÁ¤Àå¾Ö
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • electric sleep
    Àü±âÀ¯µµ¼ö¸é
  • excessive sleep inertia
    °úµµ¼ö¸é¹«·ÂÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • infant sleep apnea
    ¿µ¾Æ ¼ö¸é ¹«È£ÈíÁõ
  • phase-delayed sleep
    »óÁö¿¬¼ö¸é(ßÓòÀæÅâ²Øù)
  • primary sleep disorder
    ÀÏÂ÷¼º¡¡¼ö¸éÀå¾Ö(º´)
  • prolonged sleep
    Áö¼Ó¼ö¸é(ò¥áÙâ²Øù).
  • protracted sleep
    Áö¼Ó(¼º) ¼ö¸é(ÐüáÙàõâ²Øù).
  • Chelation therapy
    ų·¹ÀÌÆ® ¿ä¹ý
  • ECT=Electroconvulsive Therapy
    Àü±â°æ·Ã¿ä¹ý
  • EST See Electroshock therapy
    Àü±âÃæ°Ý¿ä¹ý(ï³Ñ¨õú̪èþÛö)
  • Gene therapy
    À¯ÀüÀÚÄ¡·á(ö½Öû)
  • RePUVA therapy
    ·¹Æ¼³ëÀ̵å+PUVA
  • activity therapy
    Ȱµ¿¿ä¹ý(¡­èþÛö).
  • activity therapy
    Ȱµ¿ ¿ä¹ý
  • acupuncture therapy
    ħ¼ú¿ä¹ý.
  • adaptive radiation therapy
    ÀûÀÀ¹æ»ç¼±Ä¡, ¼øÀÀ¹æ»ç¼±Ä¡·á
  • adjuvant therapy
    º¸Á¶¿ä¹ý.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ).
  • restriction enzymes
    Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ)
  • restriction fragment length polymorphism
    Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡­Òýû¡à÷)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • restriction fragment length polymorphism analysis
    Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
  • restriction fragment length polymorphism=RFLP
    Á¦ÇÑÀýÆí±æÀ̴پ缺
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • restriction, H-2
    H-2 Â÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • restriction, Ia
    IaÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • restriction, MHC
    MHCÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • restriction, genetic
    À¯ÀüÀû »óÈ£ÀÛ¿ëÁ¦ÇÑ
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö(º´), ¼ö¸é Á¶Á¤ Àå¾Ö(º´)
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • breathing related sleep disorder
    È£Èí°ü·Ã¼ö¸éÀå¾Ö(º´)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • restriction-modification system
    Á¦ÇÑ ¼ö½Ä(áóãÞ) ½Ã½ºÅÛ
  • restriction mutant
    Á¦ÇÑ º¯ÀÌü(ܨì¶ô÷)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • restriction polymorphism
    Á¦ÇÑ ´ÙÇü¼º(Òýúþàõ)
  • restriction site
    Á¦ÇÑ ÀÚ¸®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
RFLPs Restriction Fragment Length Polymorphisms; Á¦ÇÑÈ¿¼Ò´ÜÆíÀå´ÙÇü
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
RE radium emanation; readmission; rectal examination; reference emitter; reflux esophagitis; regional e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FGR Fetal growth restriction
FR Food restriction
HRF Homologous restriction factor
IUGR Intrauterine growth restriction
PCR-RFLP PCR restriction fragment length polymorphisms
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sleep disturbance
    ¼ö¸é Àå¾Ö
    ¼ö¸éÀÌ ¾çÀû, ÁúÀû ¿äÀÎÀ¸·Î Àå¾Ö¸¦ ¹Þ´Â °Í. ÃÖ±Ù ±¹Á¦Àû ºÐ·ù¿¡¼­´Â ¼ö¸é °¢¼º Àå¾Ö¶ó°í ÇÑ´Ù. ¼ö¸é Àå¾Ö´Â ºÒ¸éÁõ, °ú¸éÁõ, ¼ö¸é °¢¼º ½Ã°£
  • sleep disturbances
    ¼ö¸é Àå¾Ö
  • sleep laboratory
    ¼ö¸é °Ë»ç
  • sleep phase advance
    ¼ö¸é À§»ó ÀüÁø
  • sleep resistance
    Àá ÅõÁ¤
  • sleep terror disorder
    ¾ß°æ Àå¾Ö
    ÀáµéÀÚ °ð Àá¿¡¼­ ±ú¾î³ª °­ÇÑ ºÒ¾È°ú ÀÚÀ²½Å°æ °èÅëÀÇ Áõ»óµéÀÌ ³ªÅ¸³ª ¾Æ¹«¸® ÁøÁ¤½ÃŰ·Á ÇØµµ Àß µèÁö ¾Ê´Â »óŰ¡ µÇÇ®ÀÌÇÏ¿© ÀϾ´Â °Í.
  • acrylic splint therapy
    ¾ÆÅ©¸± ¾ÈÁ¤ ±³ÇÕ»ó Ä¡·á
  • active relaxation therapy
    ´Éµ¿ ÀÌ¿Ï ¿ä¹ý
  • adaptive radiation therapy
    ÀûÀÀ ¹æ»ç¼± Ä¡·á, ¼øÀÀ ¹æ»ç¼± Ä¡·á
  • adjunctive therapy
    ºÎ°¡ ¿ä¹ý
    ÁÖµÈ Ä¡·á °úÁ¤ ÀÌ¿ÜÀÇ Ãß°¡ Ä¡·á °úÁ¤.
  • adjuvant therapy
    º¸Á¶ ¿ä¹ý
  • anticoagulant therapy
    Ç×ÀÀ°í Ä¡·á, Ç×ÀÀ°í ¿ä¹ý
  • antimicrobial therapy
    Ç×±Õ ¿ä¹ý
  • atropine therapy
    ¾ÆÆ®·ÎÇÉ Ä¡·á, ¾ÆÆ®·ÎÇÉ ¿ä¹ý
  • aversion therapy
    Çø±â¿ä¹ý
    ¿øÇÏÁö ¾Ê´Â Çൿ ÆÐÅÏÀ» ºÒÄèÇÑ Àڱذú °áºÎ½ÃŰ´Â °Í. ¶Ç´Â ¿øÇÏÁö ¾Ê´Â ÇàÀ§·ÎºÎÅÍ ºÒÄèÇÑ ÀÚ±ØÀÌ »ý±âµµ·Ï ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ Ä¡·á.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
restriction-site polymorphism DNA polymorphism in which the sequence of one form of the polymorphism contains a recognition site for a particular endonuclease, but the sequence of the other form lacks such a site.
(05 Mar 2000)
MHC restriction <immunology> Restriction on interaction between cells of the immune system because of the requirement to recognise foreign antigen is association with MHC antigens (major histocompatibility antigens). Thus, cytotoxic T-cells will only kill virally infected cells that have the same Class I antigens as themselves, whereas helper T-cells respond to foreign antigen associated with Class II antigens.
(18 Nov 1997)
host restriction-modification A bacterial system where the bacterium is able to destroy invading DNA from a bacteriophage (virus which infects bacteria) while at the same time preventing the destruction of their own DNA. The phage DNA is cleaved by a restriction enzyme made by the bacterium, the bacterial DNA is modified (usually with methylation) so that the enzyme will not destroy it.
(09 Oct 1997)
DNA restriction enzymes <enzyme> Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of dnas, and have made it possible to splice and recombine genes from one organism into the genome of another.
Registry number: EC 3.1.21
(12 Dec 1998)
DNA restriction-modification enzymes Systems consisting of two enzymes, a modification methylase and a restriction endonuclease. They are closely related in their specificity and protect the DNA of a given bacterial species. The methylase adds methyl groups to adenine or cytosine residues in the same target sequence that constitutes the restriction enzyme binding site. The methylation renders the target site resistant to restriction, thereby protecting DNA against cleavage.
(12 Dec 1998)
ecori restriction enzyme <enzyme, molecular biology> A commonly-used restriction enzyme (enzyme which will cleave the phosphodiester bonds of DNA at specific nucleotide sequences) that came from the bacteria Escherichia coli and recognises the sequence GAATTC.
The enzyme will make a staggered cut of the double-stranded DNA molecule by cutting between the G and A on both strands.
(09 Oct 1997)
lactase restriction An inherited trait in which there is low lactase activity and thus there is defective lactose intestinal metabolism.
Compare: lactase persistence.
(05 Mar 2000)
rapid eye movement sleep REM sleep, that state of deep sleep in which rapid eye movements, alert EEG pattern, and dreaming occur; several central and autonomic functions are distinctive during this state.
(05 Mar 2000)
paradoxical sleep A deep sleep, with a brain wave pattern more like that of waking states than of other states of sleep, which occurs during rapid eye movement sleep.
(05 Mar 2000)
paroxysmal sleep <neurology> A disorder of sleep associated with excessive daytime sleepiness, involuntary daytime sleep episodes, disturbed nocturnal sleep and cataplexy.
Narcolepsy affects over 100,000 people in the United States and appears to have a genetic basis.
Symptoms usually begin in the patients twenties. Treatment often includes the use of amphetamines and-or tricyclic antidepressants.
(27 Sep 1997)
REM stage sleep <physiology> A stage of deep sleep that is accompanied by rapid eye movement and muscle paralysis. Vivid dreams can be recalled in over 80% of patients who awake from REM stage sleep.
(27 Sep 1997)
central sleep apnoea <neurology> A form of sleep apnoea which from the lack of neurologic stimulation to breathe.
(12 Jan 1998)
mixed sleep apnoea <chest medicine> A form of sleep apnoea where there is exists a combination of obstructive and central sleep apnoea syndromes.
(13 Nov 1997)
winter sleep The dormant state in which some animal species pass the winter. It is characterised by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs. It is a natural physiological process in many warm-blooded animals.
(12 Dec 1998)
multiple sleep latency test A test of the propensity to fall asleep, done by performing polysomnography during multiple brief opportunities to sleep.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sleep learning
    ¼ö¸é ÇнÀ
  • twilight sleep
    (¹«Åë ºÐ¸¸¹ýÀÇ) ¹Ý¸¶Ãë»óÅÂ
  • winter sleep
    µ¿¸é
  • therapy
    Ä¡·á; ¿ä¹ý
  • Xray therapy
    ¿¢½º¼± ¿ä¹ý
  • cell therapy
    ¼¼Æ÷¿ä¹ý(¾çÀÇ °«³­»õ³¢ÀÇ ¼¼Æ÷¸¦ ÁÖÀÔÇϴ ȸÃá¹ý ('
  • cellar therapy
    =CELL THERAPY
  • deep therapy
    ½ÉºÎ X¼± Ä¡·á(ÁÖ´ë»óÀº ¾Ç¼º Á¾¾ç)
  • electric shock therapy
    (Á¤ÀÇ)Àü±â ¼îÅ©¿ä¹ý
  • electroconvulsive therapy
    =ELECTROSHOCK THERAPY
  • electroshock therapy
    (Á¤ÀÇ)Àü±â ¼îÅ©(Ãæ°Ý)¿ä¹ý
  • family therapy
    °¡Á· ¿ä¹ý
  • fever therapy
    ¹ß¿­ ¿ä¹ý
  • fever therapy
    ¹ß¿­¿ä¹ý
  • game therapy
    À¯Àü ¿ä¹ý(À¯ÀüÀÚ °øÇп¡ ÀÇÇÑ À¯Àü»óÀÇ °áÇÕÀ» °³¼±)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á